Colgate-Palmolive Company (NYSE:CL) Shares Sold by Dynamic Advisor Solutions LLC

Dynamic Advisor Solutions LLC lessened its stake in shares of Colgate-Palmolive Company (NYSE:CL - Free Report) by 35.8% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 7,215 shares of the company's stock after selling 4,016 shares during the period. Dynamic Advisor Solutions LLC's holdings in Colgate-Palmolive were worth $676,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. Vanguard Group Inc. lifted its holdings in shares of Colgate-Palmolive by 0.7% during the fourth quarter. Vanguard Group Inc. now owns 81,303,059 shares of the company's stock worth $7,391,261,000 after purchasing an additional 588,230 shares during the period. Geode Capital Management LLC raised its position in Colgate-Palmolive by 1.6% during the 4th quarter. Geode Capital Management LLC now owns 20,518,014 shares of the company's stock worth $1,868,723,000 after buying an additional 324,683 shares during the last quarter. Norges Bank acquired a new stake in Colgate-Palmolive during the 4th quarter valued at approximately $912,375,000. Northern Trust Corp lifted its stake in Colgate-Palmolive by 11.7% during the 4th quarter. Northern Trust Corp now owns 9,497,819 shares of the company's stock valued at $863,447,000 after acquiring an additional 993,328 shares during the period. Finally, Amundi boosted its holdings in Colgate-Palmolive by 12.8% in the fourth quarter. Amundi now owns 9,200,144 shares of the company's stock valued at $806,015,000 after purchasing an additional 1,040,604 shares during the last quarter. Hedge funds and other institutional investors own 80.41% of the company's stock.

Colgate-Palmolive Price Performance

CL traded down $0.55 on Thursday, reaching $88.08. 5,107,041 shares of the company's stock were exchanged, compared to its average volume of 4,773,410. Colgate-Palmolive Company has a twelve month low of $85.32 and a twelve month high of $109.30. The stock has a market cap of $71.38 billion, a PE ratio of 24.88, a P/E/G ratio of 4.71 and a beta of 0.38. The company has a debt-to-equity ratio of 8.96, a current ratio of 0.85 and a quick ratio of 0.54. The stock's fifty day moving average price is $91.70 and its 200-day moving average price is $90.91.

Colgate-Palmolive (NYSE:CL - Get Free Report) last issued its earnings results on Friday, April 25th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.86 by $0.05. The business had revenue of $4.91 billion for the quarter, compared to analysts' expectations of $4.92 billion. Colgate-Palmolive had a return on equity of 461.04% and a net margin of 14.52%. The business's revenue for the quarter was down 3.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.86 EPS. Sell-side analysts expect that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive declared that its Board of Directors has authorized a stock repurchase plan on Thursday, March 20th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the company to buy up to 6.8% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's management believes its stock is undervalued.

Colgate-Palmolive Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, August 15th. Shareholders of record on Friday, July 18th will be paid a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.36%. The ex-dividend date is Friday, July 18th. Colgate-Palmolive's dividend payout ratio (DPR) is presently 58.76%.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on CL shares. Citigroup lifted their price target on Colgate-Palmolive from $103.00 to $108.00 and gave the company a "buy" rating in a research report on Monday, April 28th. UBS Group upped their price objective on shares of Colgate-Palmolive from $105.00 to $109.00 and gave the stock a "buy" rating in a research report on Thursday, April 17th. Piper Sandler dropped their target price on Colgate-Palmolive from $108.00 to $107.00 and set an "overweight" rating on the stock in a research report on Monday, March 31st. JPMorgan Chase & Co. upped their price target on Colgate-Palmolive from $95.00 to $103.00 and gave the stock an "overweight" rating in a report on Monday, April 28th. Finally, Barclays dropped their price objective on Colgate-Palmolive from $89.00 to $86.00 and set an "equal weight" rating on the stock in a report on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of "Hold" and an average target price of $102.12.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.